Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Breast Cancer

Free Subscription 14.05.2018 1 Am J Clin Pathol 1 Ann Oncol 1 Ann Surg 2 Anticancer Res 4 BMC Cancer 1 BMJ 1 Br J Cancer 2 Breast Cancer 11 Breast Cancer Res Treat 1 Breast J 1 Cancer Chemother Pharmacol 1 Cancer Lett 1 Cancer Res 1 Clin Breast Cancer 1 Clin Cancer Res 1 Eur J Cancer 1 Eur Radiol 1 Histopathology 2 Int J Cancer 3 Int J Oncol 3 Int J Radiat Oncol Biol Phys 1 J Nucl Med 2 JAMA 1 Lancet Oncol 1 Nat Rev Cancer 1 NPJ Breast Cancer 3 Oncogene 1 Oncol Rep 2 PLoS One 1 Proc Natl Acad Sci U S A 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Clin Pathol

1. LANDMANN A, Farrugia DJ, Zhu L, Diego EJ, et al
   Low Estrogen Receptor (ER)-Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy: Is Response Similar to Typical ER-Positive or ER-Negative Disease?
   Am J Clin Pathol. 2018 May 8. pii: 4993844. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Ann Oncol

2. CURIGLIANO G, Burstein HJ, Winer EP, Gnant M, et al
   De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
   Ann Oncol. 2018 May 3. pii: 4992289. doi: 10.1093.
   PubMed     Text format    
   
   

   
   Ann Surg

3. VAN DEN BROEK AJ, Schmidt MK, van 't Veer LJ, Oldenburg HSA, et al
   Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.
   Ann Surg. 2018 May 1. doi: 10.1097/SLA.0000000000002804.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

4. LITWIN M, Szczepanska-Buda A, Michalowska D, Grzegrzolka J, et al
   Aberrant Expression of PIWIL1 and PIWIL2 and Their Clinical Significance in Ductal Breast Carcinoma.
   Anticancer Res. 2018;38:2021-2030.
   PubMed     Text format     Abstract available
   
   
5. NIEMIEC J, Adamczyk A, Harazin-Lechowska A, Ambicka A, et al
   Podoplanin-positive Cancer-associated Stromal Fibroblasts in Primary Tumor and Synchronous Lymph Node Metastases of HER2-overexpressing Breast Carcinomas.
   Anticancer Res. 2018;38:1957-1965.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

6. DOUGAN MM, Li Y, Chu LW, Haile RW, et al
   Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry.
   BMC Cancer. 2018;18:532.
   PubMed     Text format     Abstract available
   
   
7. PENAULT-LLORCA F, Filleron T, Asselain B, Baehner FL, et al
   The 21-gene Recurrence Score(R) assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 tria
   BMC Cancer. 2018;18:526.
   PubMed     Text format     Abstract available
   
   
8. NAIK A, Al-Yahyaee A, Abdullah N, Sam JE, et al
   Neuropilin-1 promotes the oncogenic Tenascin-C/integrin beta3 pathway and modulates chemoresistance in breast cancer cells.
   BMC Cancer. 2018;18:533.
   PubMed     Text format     Abstract available
   
   
9. BANYS-PALUCHOWSKI M, Fehm T, Janni W, Aktas B, et al
   Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer.
   BMC Cancer. 2018;18:541.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

10. HAWKES N
    Breast cancer screening error: fatal mistake or lucky escape?
    BMJ. 2018;361:k2036.
    PubMed     Text format    
    
    

    
    Br J Cancer

11. FRENCH DP, Southworth J, Howell A, Harvie M, et al
    Psychological impact of providing women with personalised 10-year breast cancer risk estimates.
    Br J Cancer. 2018 May 8. pii: 10.1038/s41416-018-0069.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer

12. JAMAN MS, Sayeed MA
    Ellagic acid, sulforaphane, and ursolic acid in the prevention and therapy of breast cancer: current evidence and future perspectives.
    Breast Cancer. 2018 May 3. pii: 10.1007/s12282-018-0866.
    PubMed     Text format     Abstract available
    
    
13. TAKADA M, Takeuchi M, Suzuki E, Sato F, et al
    Real-time navigation system for sentinel lymph node biopsy in breast cancer patients using projection mapping with indocyanine green fluorescence.
    Breast Cancer. 2018 May 9. pii: 10.1007/s12282-018-0868.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res Treat

14. CUI P, Zhao Y, Chu X, He N, et al
    SNP rs2071095 in LincRNA H19 is associated with breast cancer risk.
    Breast Cancer Res Treat. 2018 May 8. pii: 10.1007/s10549-018-4814.
    PubMed     Text format     Abstract available
    
    
15. WUNDERLE M, Gass P, Haberle L, Flesch VM, et al
    BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.
    Breast Cancer Res Treat. 2018 May 3. pii: 10.1007/s10549-018-4797.
    PubMed     Text format     Abstract available
    
    
16. ABRAHAM J, Coleman R, Elias A, Holmes FA, et al
    Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG).
    Breast Cancer Res Treat. 2018 May 4. pii: 10.1007/s10549-018-4783.
    PubMed     Text format     Abstract available
    
    
17. TSUNASHIMA R, Naoi Y, Shimazu K, Kagara N, et al
    Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patients.
    Breast Cancer Res Treat. 2018 May 4. pii: 10.1007/s10549-018-4812.
    PubMed     Text format     Abstract available
    
    
18. WANG S, Beeghly-Fadiel A, Cai Q, Cai H, et al
    Gene expression in triple-negative breast cancer in relation to survival.
    Breast Cancer Res Treat. 2018 May 10. pii: 10.1007/s10549-018-4816.
    PubMed     Text format     Abstract available
    
    
19. HUANG Z, Shi Y, Bao P, Cai H, et al
    Associations of dietary intake and supplement use with post-therapy cognitive recovery in breast cancer survivors.
    Breast Cancer Res Treat. 2018 May 9. pii: 10.1007/s10549-018-4805.
    PubMed     Text format     Abstract available
    
    
20. BARDIA A, Gucalp A, DaCosta N, Gabrail N, et al
    Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer.
    Breast Cancer Res Treat. 2018 May 9. pii: 10.1007/s10549-018-4813.
    PubMed     Text format     Abstract available
    
    
21. CHOI JY, Cho EY, Choi YJ, Lee JH, et al
    Incidence and risk factors for congestive heart failure in patients with early breast cancer who received anthracycline and/or trastuzumab: a big data analysis of the Korean Health Insurance Review and Assessment service database.
    Breast Cancer Res Treat. 2018 May 8. pii: 10.1007/s10549-018-4809.
    PubMed     Text format     Abstract available
    
    
22. LOWRY KP, Braunstein LZ, Economopoulos KP, Salama L, et al
    Predictors of surveillance mammography outcomes in women with a personal history of breast cancer.
    Breast Cancer Res Treat. 2018 May 10. pii: 10.1007/s10549-018-4808.
    PubMed     Text format     Abstract available
    
    
23. DANIELS B, Kiely BE, Lord SJ, Houssami N, et al
    Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016).
    Breast Cancer Res Treat. 2018 May 7. pii: 10.1007/s10549-018-4804.
    PubMed     Text format     Abstract available
    
    
24. TELLI ML, Stover DG, Loi S, Aparicio S, et al
    Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer.
    Breast Cancer Res Treat. 2018 May 7. pii: 10.1007/s10549-018-4807.
    PubMed     Text format     Abstract available
    
    

    
    Breast J

25. KODAGANUR S, Paga U, Ram A, Krishna A, et al
    Feasibility, safety, and clinical outcomes following latissimus dorsi flap reconstruction in breast cancer- an Institutional study.
    Breast J. 2018 May 8. doi: 10.1111/tbj.13059.
    PubMed     Text format    
    
    

    
    Cancer Chemother Pharmacol

26. LITVIAKOV N, Tsyganov M, Larionova I, Ibragimova M, et al
    Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy.
    Cancer Chemother Pharmacol. 2018 May 4. pii: 10.1007/s00280-018-3594.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

27. LIU Y, Geng YH, Yang H, Yang H, et al
    Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts.
    Cancer Lett. 2018 May 4. pii: S0304-3835(18)30318.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

28. MATSUNAGA N, Ogino T, Hara Y, Tanaka T, et al
    Optimized dosing schedule based on circadian dynamics of mouse breast cancer stem cells improves the anti-tumor effects of aldehyde dehydrogenase.
    Cancer Res. 2018 May 7. pii: 0008-5472.CAN-17-4034.
    PubMed     Text format     Abstract available
    
    

    
    Clin Breast Cancer

29. KENDZIERSKI DC, Schneider BP, Kiel PJ
    Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective Review.
    Clin Breast Cancer. 2018 Apr 18. pii: S1526-8209(17)30722.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

30. BAYRAKTAR R, Ivan C, Bayraktar E, Kanlikilicer P, et al
    Dual suppressive effect of microRNA-34a on the FOXM1/eEF2-kinase axis regulates triple-negative breast cancer growth and invasion.
    Clin Cancer Res. 2018 May 10. pii: 1078-0432.CCR-17-1959.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

31. CRISCITIELLO C, Golshan M, Barry WT, Viale G, et al
    Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis.
    Eur J Cancer. 2018;97:1-6.
    PubMed     Text format     Abstract available
    
    

    
    Eur Radiol

32. VAN DER VELDEN BHM, Sutton EJ, Carbonaro LA, Pijnappel RM, et al
    Contralateral parenchymal enhancement on dynamic contrast-enhanced MRI reproduces as a biomarker of survival in ER-positive/HER2-negative breast cancer patients.
    Eur Radiol. 2018 May 7. pii: 10.1007/s00330-018-5470.
    PubMed     Text format     Abstract available
    
    

    
    Histopathology

33. AFFLECK A, Lyman WB, Jacobs WC, Livasy CA, et al
    Metastatic breast cancer to the liver with hepatoid features and Hep Par 1 antibody positive mimicking hepatocellular carcinoma.
    Histopathology. 2018 May 9. doi: 10.1111/his.13644.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

34. OH E, Kim YJ, An H, Sung D, et al
    Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
    Int J Cancer. 2018 May 9. doi: 10.1002/ijc.31585.
    PubMed     Text format     Abstract available
    
    
35. FAN C, Zhang J, Ouyang T, Li J, et al
    RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
    Int J Cancer. 2018 May 4. doi: 10.1002/ijc.31579.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

36. KIM JY, Kim JC, Lee JY, Park MJ, et al
    Oct4 suppresses IRinduced premature senescence in breast cancer cells through STAT3- and NFkappaB-mediated IL24 production.
    Int J Oncol. 2018 May 2. doi: 10.3892/ijo.2018.4391.
    PubMed     Text format     Abstract available
    
    
37. CHENG CC, Shi LH, Wang XJ, Wang SX, et al
    Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Int J Oncol. 2018 May 8. doi: 10.3892/ijo.2018.4399.
    PubMed     Text format     Abstract available
    
    
38. TAN Y, Zhou G, Wang X, Chen W, et al
    USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway.
    Int J Oncol. 2018 Apr 30. doi: 10.3892/ijo.2018.4387.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

39. BELKACEMI Y, Smith BD, Horton JK
    Regional Nodal Irradiation in the Modern Era of Breast Cancer Management.
    Int J Radiat Oncol Biol Phys. 2018;101:241-243.
    PubMed     Text format    
    
    
40. HO AY, Olm-Shipman M, Zhang Z, Siu CT, et al
    A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
    Int J Radiat Oncol Biol Phys. 2018;101:325-333.
    PubMed     Text format     Abstract available
    
    
41. 
    Erratum to: Woodward WA, Fang P, Arriaga L, et al. A phase 2 study of preoperative capecitabine and concomitant radiation in women with advanced breast cancer. Int J Radiat Oncol Biol Phys 2017;99:777-783.
    Int J Radiat Oncol Biol Phys. 2018;101:497.
    PubMed     Text format    
    
    

    
    J Nucl Med

42. PETERSON LM, O'Sullivan J, Wu QV, Novakova-Jiresova A, et al
    Prospective study of serial (18)F-FDG PET and (18)F-fluoride ((18)F-NaF) PET to predict time to skeletal related events, time-to-progression, and survival in patients with bone-dominant metastatic breast cancer.
    J Nucl Med. 2018 May 10. pii: jnumed.118.211102. doi: 10.2967/jnumed.118.211102.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

43. VAN SMEDEN M, Van Calster B, Groenwold RHH
    Machine Learning Compared With Pathologist Assessment.
    JAMA. 2018;319:1725-1726.
    PubMed     Text format    
    
    
44. BEJNORDI BE, Litjens G, van der Laak JA
    Machine Learning Compared With Pathologist Assessment-Reply.
    JAMA. 2018;319:1726.
    PubMed     Text format    
    
    

    
    Lancet Oncol

45. GOURD E
    Low uptake of tamoxifen to prevent breast cancer.
    Lancet Oncol. 2018 May 3. pii: S1470-2045(18)30344.
    PubMed     Text format    
    
    

    
    Nat Rev Cancer

46. LIM B, Woodward WA, Wang X, Reuben JM, et al
    Author Correction: Inflammatory breast cancer biology: the tumour microenvironment is key.
    Nat Rev Cancer. 2018 May 10. pii: 10.1038/s41568-018-0022.
    PubMed     Text format     Abstract available
    
    

    
    NPJ Breast Cancer

47. POWELL E, Shao J, Picon HM, Bristow C, et al
    A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis.
    NPJ Breast Cancer. 2018;4:9.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

48. BAKER A, Wyatt D, Bocchetta M, Li J, et al
    Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0251.
    PubMed     Text format     Abstract available
    
    
49. PAREKH A, Das S, Parida S, Das CK, et al
    Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0272.
    PubMed     Text format     Abstract available
    
    
50. ROGERS S, McCloy RA, Parker BL, Gallego-Ortega D, et al
    MASTL overexpression promotes chromosome instability and metastasis in breast cancer.
    Oncogene. 2018 May 10. pii: 10.1038/s41388-018-0295.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

51. CHOI JW, Moon BI, Lee JW, Kim HJ, et al
    Use of CA153 for screening breast cancer: An antibodylectin sandwich assay for detecting glycosylation of CA153 in sera.
    Oncol Rep. 2018 May 10. doi: 10.3892/or.2018.6433.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

52. KOVAC B, Makela TP, Vallenius T
    Increased alpha-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer.
    PLoS One. 2018;13:e0196986.
    PubMed     Text format     Abstract available
    
    
53. SENARAS C, Niazi MKK, Sahiner B, Pennell MP, et al
    Optimized generation of high-resolution phantom images using cGAN: Application to quantification of Ki67 breast cancer images.
    PLoS One. 2018;13:e0196846.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

54. LAI X, Stiff A, Duggan M, Wesolowski R, et al
    Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors.
    Proc Natl Acad Sci U S A. 2018 May 7. pii: 1721559115.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

55. CAUMO F, Zorzi M, Brunelli S, Romanucci G, et al
    Digital Breast Tomosynthesis with Synthesized Two-Dimensional Images versus Full-Field Digital Mammography for Population Screening: Outcomes from the Verona Screening Program.
    Radiology. 2017 Dec 13:170745. doi: 10.1148/radiol.2017170745.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: